Lung tumor motion due to respiration poses a challenge in the application of 10 modern three-dimensional conformal radiotherapy. Direct tracking of the lung tumor during radiation therapy is very difficult without implanted fiducial markers. Indirect tracking relies on the correlation of the tumor's motion and the surrogate's motion. The present paper presents an analysis of the correlation between the tumor motion and the diaphragm motion in order to evaluate the 15 potential use of diaphragm as a surrogate for tumor motion. We have analyzed the correlation between diaphragm motion and superior-inferior lung tumor motion in 32 fluoroscopic image sequences from 10 lung cancer patients. A simple linear model and a more complex linear model that accounts for phase delays between the two motions have been used. Results show that the 20 diaphragm is a good surrogate for tumor motion prediction for most patients, resulting in an average correlation factor of 0.94 and 0.98 with each model respectively. The model that accounts for delays leads to an average localization prediction error of 0.8mm and an error at the 95% confidence level of 2.1mm. However, for one patient studied, the correlation is much weaker compared to 25 other patients. This indicates that, before using diaphragm for lung tumor prediction, the correlation should be examined on a patient-by-patient basis.
Introduction

30
It has been shown that modern three-dimensional radiation therapy is more successful at treating early stage lung cancer than older two-dimensional radiation therapy (Fang et al., 2006) . There is, however, a concern related to respiratory tumor motion. It has been shown that the motion amplitude can be clinically significant (~2-3 cm) (Keall et al., 2006) , depending on tumor location and individual patients. Tumor motion may greatly 35 degrade the effectiveness of conformal radiotherapy for the management of lung cancer, especially when the treatment is done in a hypofractionated or single-fraction manner.
Various tumor motion compensation strategies have been investigated (Keall et al., 2006; Jiang, 2006a) . Advanced motion compensation techniques, such as beam gating (Jiang, 2006b) or beam tracking (Keall et al., 2001) , rely on the precise knowledge of tumor position. There are mainly four different methods to determine tumor location during the treatment: 1) direct fluoroscopic tumor tracking (Cui et al., 2007; Xu et al., 5 2007; Xu et al., 2008) ; 2) fluoroscopic tracking of the implanted fiducial markers (Sharp et al., 2004; Tang et al., 2007) ; 3) inference of the tumor position from anatomic surrogates such as abdomen surface (Berbeco et al., 2005b; Berbeco et al., 2006; Wu et al., 2008) ; and 4) non-radiographical tumor tracking through implanted transponders (Seiler et al., 2000; Balter et al., 2005) .
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Tumor tracking techniques based on implanted fiducial markers or wireless transponders, when applied to lung cancer, suffer from various clinical problems, such as the risks of pneumothorax (Geraghty et al., 2003; Arslan et al., 2002) and marker migration (Nelson et al., 2007) . Therefore, these techniques are not suitable for lung tumor tracking. Techniques for direct fluoroscopic lung tumor tracking are still under 15 development and there is a long way to go before its clinical use (Cui et al., 2007; Xu et al., 2007; Xu et al., 2008; Lin et al., 2009) . Tumor localization based on anatomic surrogates has been implemented clinically for gated lung cancer radiotherapy, using commercial products such as the Real-Time Position Management (RPM) system (Varian Medical Systems, Inc, Pala Alto, CA, USA) (Jiang, 2006b ). This kind of techniques is 20 accurate only when there is a good correlation between lung tumor motion and the motion of the anatomic surrogate. Therefore, it is crucial to have a clear understanding on the correlation between tumor and a particular surrogate before this surrogate is used to derive the tumor location.
The most commonly used anatomic surrogate is the antero-posterior (AP) motion of 25 the abdominal surface (Jiang, 2006b; Kanoulas et al., 2007; Wu et al., 2008; Ruan et al., 2008) . Vedam et al have shown that the abdominal surface motion correlates strongly with diaphragm motion (Vedam et al., 2003) . However, some other studies show that the correlation between tumor motion and abdominal surface motion or between abdominal surface motion and diaphragm motion depends on individual patients and treatment 30 fractions and cannot be generalized (Bruce, 1996; Hoisak et al., 2004 Hoisak et al., , 2006 Tsunashima et al., 2004) . When abdominal surface motion is used to generate gating signal, the tumor residual motion can be large (Berbeco et al., 2005b; Berbeco et al., 2006) and about 30% of the time the radiation beam will miss the target (Wu et al., 2008) . Patient breath coaching or updating the internal/external correlation using low frequency x-ray imaging 35 can improve the accuracy gated radiotherapy based on abdominal surface motion (Jiang, 2006b; Kanoulas et al., 2007; Wu et al., 2008) . Intuitively, anatomic surrogates inside the thorax, such as carina or diaphragm, should correlate better with lung tumor motion compared to abdominal surface. Van der Weide et al. found that there is a good correlation between carina and lung tumor motion 40 and concluded that carina is a better internal surrogate than diaphragm (van der Weide et al., 2008) . However, when estimating the correlation between diaphragm and lung tumor motion, they did not take in account the phase shift between two motions, which underestimates the correlation. Zhang et al. evaluated tumor position prediction from diaphragm with a linear model that compensated for phase shift between tumor and diaphragm motions (Zhang et al., 2007) . They performed the study only for 4 patients. Both studies are based on 4D-CT data, which consists on only one fictitious breathing cycle. We believe that the diaphragm is more suitable than carina for clinical application 5 due to its high visibility in fluoroscopic images, if there is a good correlation between diaphragm and lung tumor motion. Therefore, we feel there is a need to carefully and comprehensively examine the correlation of lung tumor position with diaphragm position using image sequences consisting on many breathing cycles.
The goal of this project is to analyze the correlation between the motions of the 10 diaphragm and the lung tumor in order to evaluate whether diaphragm can be used as an internal anatomic surrogate for predicting lung tumor position. Diaphragm, as opposed to tumor, can be easily detected in fluoroscopic images (Chen et al., 2001; Berbeco et al., 2005a; Vedam et al., 2003) .
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Methods and Materials
Patient image data
A retrospective analysis was performed based on 32 AP fluoroscopic sequences from 10 20 different lung cancer patients who underwent hypofractionated radiotherapy at the Moores Cancer Center, University of California San Diego (UCSD). The fluoroscopic images were acquired before or after treatment, at different treatment fractions, using an on-board x-ray imaging (OBI) system (Varian Medical Systems, Inc., Palo Alto, CA, USA). Each fluoroscopic sequence consists of an average of 513 images (320 to 701) that 25 were acquired at a rate of 15 frames per second. Each image has 1024x768 pixels, with pixel size of either 0.243mm or 0.259mm, depending on the sequence. Tumor position was manually marked in each frame by an expert observer, and was considered as the ground truth. When tumor was not easily identified in the fluoroscopic sequence, an anatomical feature close to the tumor and easy to detect was marked instead. The 30 position of diaphragm was automatically detected by thresholding the image and applying a maximum gradient algorithm. The position of the apex of the diaphragm was recorded for all the sequences and frames.
Overview of the model construction
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In order to observe the correlation between diaphragm and tumor motions, two different models for tumor motion prediction based on diaphragm motion were developed. First we used a linear model where tumor position was derived from the concurrent diaphragm position (Model 1). Then, to take into account the possible phase shift between tumor 40 motion and diaphragm motion, we developed a more complex linear model where the concurrent diaphragm position and an optimal set of past positions of the diaphragm were considered as surrogates (Model 2). Two different analyses were performed on both models: 1) a goodness of fit study, where the models were built based on all the images of the sequence, i.e., training set consisted on all the images in the sequence; and 2) a prediction power study, where the models were built based on the first 200 images (training set), corresponding to 13.3 seconds, and prediction errors were computed during the rest of the sequence (testing set). In order to eliminate the noise inherent to the 5 manual identification of the tumor position, tumor trajectories were filtered (in time) using a 5-point median filter. All our algorithms have been implemented on Matlab 7.4 platform.
Model construction
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Two different sets of surrogates have been considered for each patient, resulting in two different models (Model 1 and Model 2). Both models follow a procedure similar to that described by Zhang et al (2007) . The objective of these models is to establish the linear relationship between tumor displacement ˜ y (t) and surrogate displacement˜ s (t) :
where , and performing a Principal Component Analysis (PCA) on p(t) (notice that there are only as many as N principal components), we can express any p(t) as a linear combination of the eigenvectors obtained from the PCA:
where e k are the eigenvectors of the analysis (components), w k are the corresponding coefficients in the linear combination, and p  [ y ,s 1 ,...,s N ] is the mean value of p(t). Eq.
(2) can be written in matrix form as: 
where E y and E s are the upper row and the N lower rows of E respectively. Eliminating W in Eq. 4 and assuming that E s is invertible, we obtain:
which is the relationship we were looking for in Eq. (1).
5
Model 1 (one surrogate): for the construction of the first model the position of the tumor y 0 at time t 0 is derived from only one surrogate, i.e., the position of the diaphragm s 0 at the same time instant (see Figure 1 ). The equation of the model is: 
We have selected a maximum N of 20, which allows for more than 1 second delay between motions. An exhaustive search among all the possible subsets of these surrogates to find the optimal subset would lead to about 0.5 million searches. Instead, a subset of surrogates close to optimal was obtained by the Sequential Forward Floating Search (SFFS) (Pudil et al., 1994) . Sequential feature selection algorithms search for features in 10 a sequential deterministic manner to find a suboptimal subset of features with respect to an evaluation criterion J. Forward methods start with an empty subset and sequentially add new features to achieve optimality. SFFS is a feature selection technique that provides close to optimal solution at an affordable computational cost (Jain et al., 2000) . The SFFS method comprises the following steps:
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Step 1: Inclusion (Sequential Forward Search, SFS)
Step 2: Conditional exclusion
Step 3: Continuation of conditional exclusion 20 At Step 1 one feature among the available features is added to the surrogate subset, so that the new subset maximizes the evaluation criterion J. At Step 2 a conditional exclusion is performed, that is, the worst feature in the updated subset is excluded from the set if by doing so a best evaluation criterion J is achieved. At Step 3 conditional exclusion steps continue until no further improvement in J is achieved. These 3 steps are 25 iteratively repeated until no further improvement in J is found.
In this study, the selection criterion J used for the feature selection in the SFFS method is the correlation coefficient obtained between the tumor position trajectory and the predicted position given by the selected surrogates during the training set.
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Goodness of fit
In order to evaluate correlation, a Pearson's correlation test was performed. Models 1 and 2 were built based on the diaphragm position and the tumor position in the whole fluoroscopic sequence, for each sequence individually. The correlation between the real 35 tumor position and the predicted tumor position given by each models was calculated, as well as the mean error ē and the maximum error at the 95% confidence interval e 95 of the prediction.
In addition, Model 1 has been used for comparison of model parameters between 40 different sequences of the same patient. We focus on variability of the slope b in Eq. (5) of these models and the correlation coefficient of tumor and diaphragm motions for each patient. Variability has been computed as a percentage by calculating the standard deviation of the parameters divided by the average, and multiplying by 100. 5
Prediction power
In addition to calculating the correlation coefficient, an evaluation of the predictability of the models was performed. In this case, the first 200 frames of each sequence were used as the training set to build Models 1 and 2, and the remaining frames in the same session 10 were used as testing data. For every sequence, models built with the training set were applied to predict tumor position in the testing set. Mean prediction error ē and 95-percentile prediction error e 95 are computed in the testing set in each sequence. Table 1 shows, for each patient, the number of sequences analyzed, the average tumor motion range, the average delay between diaphragm and tumor motion, and the average 20 distance between tumor and diaphragm. It can be observed that the average tumor motion ranged from 12 to 24mm, although individual sequence values ranged from 9mm to 35mm. The average motion range among all the patients and sequences was found to be 17mm. Delay between diaphragm and tumor motions was calculated with cross correlation of both signals (tumor and diaphragm trajectories). Mean delay and standard 25 deviation are given for patients with more than one fluoroscopic sequence. Patients with several fluoroscopic sequences show a constant delay throughout all the series. Patient 2 shows a standard deviation of 0.15 sec, mainly due to the fact that in some sessions the patient remains without breathing for prolonged periods of time, which affects the calculation of the delay. Figure 2 shows the general trend of model performance for most patients: Model 1 (red 5 hollow circles) proves a good correlation between diaphragm and tumor motion, which can be further improved by adding surrogates from the diaphragm history in Model 2 (blue solid circles). A detail of the true target position and modeled position is shown. It can be seen that Model 2 corrects for a slight phase delay between diaphragm and target motions. The usual number of surrogates in the optimal subset ranges from 2 to 4 10 surrogates. Although different sequences of the same patient may use a different subset of surrogates, they are similar. it is always larger than 0.94 except for Patient3, who presents a correlation coefficient of 0.76. It can be observed that Model 2 gives an average correlation value of 0.98 (range 0.95-1.00). Model 2 gives smaller mean error (p<0.01) and 95-percentile error (p<0.01) and higher correlation coefficients (p<0.03) compared to Model 1. Model 2 gives an e 95 of less than 2.3mm except for Patient3. 
Results
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Data analysis
30
Correlation between diaphragm and tumor motions
30
Prediction power
10
To examine the prediction power of models for tumor locations based on diaphragm positions as surrogates, the first 200 frames of each sequence were used to build both models (training set) in each sequence independently. These models were used to predict tumor position in the remaining frames of the same sequence (testing set). The average correlation between real and predicted tumor position, and the average prediction errors ē
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and e 95 of all sequences in each patient and the total average for all patients are shown in Figure 3 shows the prediction error for models 1 and 2 for all the patients and all the sequences. Model 2 gives smaller errors than Model 1 in all the studied cases. We have studied whether there is any correlation between motion range or tumordiaphragm distance and prediction error. Figure 4 shows the 95-percentile error e 95 versus the motion range for all the fluoroscopic sequences, as well as a linear fit to this data. An 10 increase of error with motion range is observed, although the R-square value of this fit is small. Figure 5 shows e 95 versus the distance between diaphragm and tumor mean positions for each sequence, and the linear fit to this data. The small R-square value of this fit indicates that there is no correlation between both magnitudes. 
Outlier Patient
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During the model evaluation and correlation study we observed that all the patients showed good correlation factors and good model predictions, except for Patient 3. After analyzing one of Patient3's sequences visually, we observed that the motion inside this patient's lung seems at times inconsistent. For example, at times some structures inside 10 the lung move while the diaphragm remains static (two different snapshots of one of the sequences of Patient3 are shown in Figure 6 ). These two temporary uncorrelated motions, possibly due to coughing, led to low overall correlation factors and poor model predictions. Analysis of the two other sequences of the same patient did not lead to any observation of such inconsistency in motion. Results, however, although better than in 15 the sequence previously mentioned, were still worse than for other patients (prediction e 95 with Model 2 was 5.3mm and 3.6mm). 
Discussion and conclusions
This paper presents a study of the correlation between diaphragm motion and tumor 10 craniocaudal motion based on 32 fluoroscopic sequences of 10 different lung cancer patients. The correlation factor has been shown to be very good, especially with Model 2 (which compensates for phase shifts), being always superior to 0.95, and leading to an average prediction error of 0.8mm and error at a 95% confidence level of 2.1mm. The small prediction error and the high correlation between diaphragm position and tumor 15 position with the linear models used in this work lead to the conclusion that diaphragm motion is a good surrogate for indirect tumor position estimation. It should be noted that if non-linear models were considered in addition to linear models, results should improve, or at least not get worse. Gated treatment or tumor tracking can clearly benefit from the good correlation here found. While tumor is not always visible in fluoroscopic 20 images and it cannot be directly tracked, the diaphragm has a high contrast edge that can be automatically identified at the required rate for a successful online estimation and treatment. diaphragm It has been observed that the correlation between diaphragm motion and tumor motion varies from patient to patient. Therefore a specific training set to build the model should be used for each individual. While performance of the models here developed show that in general there is a linear (and therefore predictable) relationship between diaphragm and tumor motion, this has not been the case for Patient3. Although adding 5 new surrogates to the model seems to improve the results, error is still larger than desired. Therefore the appropriateness of a linear relationship between diaphragm and tumor motions should be assessed for every patient. Patients like Patient3 in this study, who present a difference in the shape of diaphragm motion trajectory and tumor motion trajectory that cannot be explained by a simple amplitude change and time delay, might 10 benefit from the development of a non-linear model.
We would like to acknowledge that one limitation of the presented study is that it only considers craniocaudal tumor motion. Lateral and AP motions usually have smaller amplitude than superior-inferior motion, and lead to large noise in the marked trajectory when fluoroscopic images are manually marked. Although it is expected that the 15 correlation of diaphragm motion and lateral and AP tumor motion is also good, a similar study where the 2D or 3D tumor position is known should be performed in the future.
In our prediction power study 200 images were used to build the prediction model. In contrast, other correlation studies normally use 4D-CT images, which consist on about 10 breathing phases (van der Weide et al., 2008; Zhang et al., 2007) . One of the problems of 20 these 4D-CT studies is that the scans at the diaphragm axial position and the scans at each tumor position correspond to different breathing cycles, which might have different breathing amplitudes. Once scans are divided into phase bins, although corresponding to the same breathing phase, they might correspond to different amplitudes, and therefore diaphragm position in one of those bins might not correspond to the tumor position 25 identified in the same bin. We believe that a study that uses real time position is more accurate than using 4D-CT data. This paper only intended to evaluate correlation of tumor and diaphragm. Variability of the model correlation and slope throughout different sequences has been analyzed in several patients. A future study will evaluate whether the model built for one treatment 30 fraction can predict motion during a different fraction or inter-fraction variation of the correlation is too large to use the model from one fraction for prediction in another fraction.
In summary, radiotherapy treatments based on surrogate imaging rely on the good correlation of the tumor motion with respect to the surrogate. We have seen in the present 35 study that this correlation is good when using diaphragm as a surrogate, and that it can be improved by using more sophisticated correlation models. However, this correlation is patient specific, and it should be examined for each patient individually before it is used for deriving the tumor position. 
